In contrast, the GSTM1 present /GSTT1 null and GSTM1 null/GSTT1 present genotypes were not associated with a CML risk (p-value=0.064 and 0.061 respectively), see Table 2. This evidence concerns the gene GSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive.